CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway

[1]  R. Green,et al.  A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion , 2021, Nature Communications.

[2]  C. Farinha,et al.  Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation. , 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  S. Crooke,et al.  Antisense technology: A review , 2021, The Journal of biological chemistry.

[4]  Guramrit Singh,et al.  The Branched Nature of the Nonsense-Mediated mRNA Decay Pathway. , 2020, Trends in genetics : TIG.

[5]  E. Kerem.  ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease , 2020, Expert opinion on investigational drugs.

[6]  Yi-Tao Yu,et al.  Suppression of Nonsense Mutations by New Emerging Technologies , 2020, International journal of molecular sciences.

[7]  T. Hwang,et al.  Positional effects of premature termination codons on the biochemical and biophysical properties of CFTR , 2020, The Journal of physiology.

[8]  Anat Frydman-Marom,et al.  Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX‐02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers , 2019, Clinical pharmacology in drug development.

[9]  R. Green,et al.  Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides , 2019, bioRxiv.

[10]  C. Merlo,et al.  Decreased mRNA and protein stability of W1282X limits response to modulator therapy. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[11]  Shuling Guo,et al.  Nonsense Mediated RNA Decay Pathway Inhibition Restores Expression and Function of W1282X CFTR. , 2019, American journal of respiratory cell and molecular biology.

[12]  Shuling Guo,et al.  Targeting Translation Termination Machinery with Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations , 2019, Nucleic acid therapeutics.

[13]  H. Bui,et al.  Steric Inhibition of 5′ UTR Regulatory Elements Results in Upregulation of Human CFTR , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  A. Sivachenko,et al.  Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[15]  C. Merlo,et al.  Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis , 2018, PLoS genetics.

[16]  E. Ziętkiewicz,et al.  Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons , 2018, Molecular medicine.

[17]  Shuling Guo,et al.  Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutations , 2018, Genome Biology.

[18]  D. Bedwell,et al.  Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences , 2017, Human molecular genetics.

[19]  Christopher R. Sibley,et al.  Transcript-specific characteristics determine the contribution of endo- and exonucleolytic decay pathways during the degradation of nonsense-mediated decay substrates , 2017, RNA.

[20]  T. CrookeStanley.  Molecular Mechanisms of Antisense Oligonucleotides. , 2017 .

[21]  O. Mühlemann,et al.  Transcriptome-wide identification of NMD-targeted human mRNAs reveals extensive redundancy between SMG6- and SMG7-mediated degradation pathways , 2017, RNA.

[22]  J. Foskett.  CFTR nonsense mutations: Therapeutic benefits from clinically approved drugs? , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[23]  G. Lukács,et al.  Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product*♦ , 2016, The Journal of Biological Chemistry.

[24]  B. Porse,et al.  UPF2-Dependent Nonsense-Mediated mRNA Decay Pathway Is Essential for Spermatogenesis by Selectively Eliminating Longer 3'UTR Transcripts , 2016, PLoS genetics.

[25]  U. Wolfrum,et al.  Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs) , 2016, BioDrugs.

[26]  Shuling Guo,et al.  Knockdown of nuclear-retained long noncoding RNAs using modified DNA antisense oligonucleotides. , 2015, Methods in molecular biology.

[27]  C. Goss,et al.  Cystic fibrosis , 2015, Nature Reviews Disease Primers.

[28]  A. Sandelin,et al.  Human nonsense-mediated RNA decay initiates widely by endonucleolysis and targets snoRNA host genes , 2014, Genes & development.

[29]  L. Maquat,et al.  A post-translational regulatory switch on UPF1 controls targeted mRNA degradation , 2014, Genes & development.

[30]  O. Mühlemann,et al.  A novel phosphorylation-independent interaction between SMG6 and UPF1 is essential for human NMD , 2014, Nucleic acids research.

[31]  A. Hinzpeter,et al.  Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies. , 2014, The international journal of biochemistry & cell biology.

[32]  K. De Boeck,et al.  The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[33]  E. Izaurralde,et al.  The SMG5–SMG7 heterodimer directly recruits the CCR4–NOT deadenylase complex to mRNAs containing nonsense codons via interaction with POP2 , 2013, Genes & development.

[34]  Osamu Onodera,et al.  Inhibition of SMG-8, a subunit of SMG-1 kinase, ameliorates nonsense-mediated mRNA decay-exacerbated mutant phenotypes without cytotoxicity , 2013, Proceedings of the National Academy of Sciences.

[35]  M. Wilkinson,et al.  Regulation of nonsense‐mediated mRNA decay , 2012, Wiley interdisciplinary reviews. RNA.

[36]  M. Okoniewski,et al.  Autoregulation of the nonsense-mediated mRNA decay pathway in human cells. , 2011, RNA.

[37]  D. Bedwell,et al.  Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases , 2011, Wiley interdisciplinary reviews. RNA.

[38]  E. Stone,et al.  RNA homeostasis governed by cell type-specific and branched feedback loops acting on NMD. , 2011, Molecular cell.

[39]  H. Schneider,et al.  Efficiency of translation termination in humans is highly dependent upon nucleotides in the neighbourhood of a (premature) termination codon , 2011, Journal of Medical Genetics.

[40]  M. Amaral,et al.  Deletion of CFTR Translation Start Site Reveals Functional Isoforms of the Protein in CF Patients , 2009, Cellular Physiology and Biochemistry.

[41]  J. Gécz,et al.  A UPF3-mediated regulatory switch that maintains RNA surveillance , 2009, Nature Structural &Molecular Biology.

[42]  H. Hirano,et al.  SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay. , 2009, Genes & development.

[43]  Matthew Mort,et al.  A meta‐analysis of nonsense mutations causing human genetic disease , 2008, Human mutation.

[44]  F. Bonneau,et al.  NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity , 2008, Nature Structural &Molecular Biology.

[45]  J. Clancy,et al.  Restoration of W1282X CFTR activity by enhanced expression. , 2007, American journal of respiratory cell and molecular biology.

[46]  M. Wilkinson,et al.  An alternative branch of the nonsense‐mediated decay pathway , 2007, The EMBO journal.

[47]  B. Kerem,et al.  Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. , 2007, The Journal of clinical investigation.

[48]  M. Hentze,et al.  Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. , 2005, Molecular cell.

[49]  Jean-Pierre Rousset,et al.  UAG readthrough in mammalian cells: Effect of upstream and downstream stop codon contexts reveal different signals , 2001, BMC Molecular Biology.

[50]  D. Bedwell,et al.  Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. , 2000, RNA.

[51]  L. Maquat,et al.  Evidence that translation reinitiation abrogates nonsense‐mediated mRNA decay in mammalian cells , 1997, The EMBO journal.

[52]  D. Bedwell,et al.  The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. , 1995, Journal of molecular biology.

[53]  T. Flotte,et al.  Alternate Translation Initiation Codons Can Create Functional Forms of Cystic Fibrosis Transmembrane Conductance Regulator (*) , 1995, The Journal of Biological Chemistry.

[54]  L. Chin,et al.  CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. , 1994, American journal of respiratory cell and molecular biology.